These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs. Thomas D; Ali Z; Zachariah S; Sundararaj KGS; Van Cuyk M; Cooper JC Am J Cardiovasc Drugs; 2017 Oct; 17(5):343-346. PubMed ID: 28353025 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Hermann M; Ruschitzka F Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448 [TBL] [Abstract][Full Text] [Related]
7. Coxibs: is there a benefit when compared to traditional non-selective NSAIDs in postoperative pain management? Wickerts L; Warrén Stomberg M; Brattwall M; Jakobsson J Minerva Anestesiol; 2011 Nov; 77(11):1084-98. PubMed ID: 21617597 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory drugs in the 21st century. Rainsford KD Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044 [TBL] [Abstract][Full Text] [Related]
9. COX-2 inhibitors and the heart: are all coxibs the same? Sooriakumaran P Postgrad Med J; 2006 Apr; 82(966):242-5. PubMed ID: 16597810 [TBL] [Abstract][Full Text] [Related]
10. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs]. Lange H; Eberhart L Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular issues of COX-2 inhibitors and NSAIDs. Wong M; Chowienczyk P; Kirkham B Aust Fam Physician; 2005 Nov; 34(11):945-8. PubMed ID: 16299629 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man. Dajani EZ; Islam K J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633 [TBL] [Abstract][Full Text] [Related]
13. COX-2 selective inhibitors in the treatment of osteoarthritis. Laine L; White WB; Rostom A; Hochberg M Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922 [TBL] [Abstract][Full Text] [Related]
14. Clinical Pharmacology and Cardiovascular Safety of Naproxen. Angiolillo DJ; Weisman SM Am J Cardiovasc Drugs; 2017 Apr; 17(2):97-107. PubMed ID: 27826802 [TBL] [Abstract][Full Text] [Related]
15. [Drug safety of NSAIDs and COX-2 inhibitors]. Herdegen T; Fauler J Med Monatsschr Pharm; 2006 Apr; 29(4):122-8. PubMed ID: 16628961 [TBL] [Abstract][Full Text] [Related]
16. How to advise aspirin use in patients who need NSAIDs. Sopena F; Lanas A Curr Pharm Des; 2007; 13(22):2248-60. PubMed ID: 17691998 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular complications of non-steroidal anti-inflammatory drugs. Fosslien E Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of coxibs. Caporali R; Montecucco C Lupus; 2005; 14(9):785-8. PubMed ID: 16218488 [TBL] [Abstract][Full Text] [Related]
20. [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]. Valat JP; Deray G; Héloire F Presse Med; 2006 Sep; 35(9 Spec No 1):1S25-34. PubMed ID: 17078592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]